02/07/2024 - Annovis Bio Inc.: July 2, 2024Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap

The text version of this document is not available. You can access the original document here.

Attachments

• Original Link
• Permalink

Disclaimer

Annovis Bio Inc. published this content on 02 July 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 July 2024 12:08:20 UTC.